Teva: FDA gives final approval for Ondansetron injection By Gabriel Madway Published: Nov. 22, 2006, 1:54 p.m. ET Share ...

Metoclopramide Injection 10mg/2mL (5mg/mL), NDC 0409-3414-01, Lot 28-104-DK (the lot number may be followed by a 01); packaged in a 2mL single-dose fliptop vial, expiration date: 10/1/14 ...

Please read this leaflet carefully before you use ONDANSETRON VIATRIS solution for injection. This leaflet answers some common questions about ONDANSETRON VIATRIS. It does not contain all the ...

For the 12 months ending December 2009, Ondansetron Injection, USP, 2 mg/mL had U.S. sales of approximately $58 million at Average Wholesale Price. A launch date for the product has not been set.

MUMBAI, April 24 (Reuters) - Strides Arcolab Ltd said on Thursday the U.S. Food and Drug Administration had approved two of its ondansetron injections. The drug is licensed to Akorn-Strides LLC, a ...

Ondansetron Injection, USP is indicated for prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including high-dose cisplatin, and for ...

Sales of Zofran injection in the United States during the 12 months to Sept. 30 were $628 million, Wockhardt said. This is Wockhardt's eighth FDA approval in 2006.

Ondansetron HCl is a white to off-white powder that is soluble in water and normal saline. Each 1 mL of aqueous solution in the mL multidose vial contains 2 mg of ondansetron as the hydrochloride ...

The FDA has given tentative approval to Baxter Healthcare's ondansetron injection for the prevention of nausea and vomiting. Baxter says that final approval should come in December. Report ...